Cargando…

Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis

AIMS: Lowering low-density lipoprotein cholesterol (LDL-C) reduces cardiovascular risk irrespective of age, but the evidence is less strong for older patients. METHODS AND RESULTS: This prespecified analysis from ODYSSEY OUTCOMES compared the effect of alirocumab vs. placebo in 18 924 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sinnaeve, Peter R, Schwartz, Gregory G, Wojdyla, Daniel M, Alings, Marco, Bhatt, Deepak L, Bittner, Vera A, Chiang, Chern-En, Correa Flores, Roger M, Diaz, Rafael, Dorobantu, Maria, Goodman, Shaun G, Jukema, J Wouter, Kim, Yong-Un, Pordy, Robert, Roe, Matthew T, Sy, Rody G, Szarek, Michael, White, Harvey D, Zeiher, Andreas M, Steg, Ph Gabriel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Fast Track Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308542/ https://www.ncbi.nlm.nih.gov/pubmed/31732742 http://dx.doi.org/10.1093/eurheartj/ehz809

Ejemplares similares

Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial
por: White, Harvey D, et al.
Publicado: (2019)

Transiently achieved very low low-density lipoprotein cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial
por: Schwartz, Gregory G, et al.
Publicado: (2023)

Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES
por: Jukema, J. Wouter, et al.
Publicado: (2019)

Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial
por: Szarek, Michael, et al.
Publicado: (2020)

Effect of Alirocumab on Mortality After Acute Coronary Syndromes: An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial
por: Steg, Philippe Gabriel, et al.
Publicado: (2019)

Alirocumab after acute coronary syndrome in patients with a history of heart failure
por: White, Harvey D, et al.
Publicado: (2021)

Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial
por: Schwartz, Gregory G., et al.
Publicado: (2020)

Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial
por: Tuñón, José, et al.
Publicado: (2020)

Clinical Efficacy and Safety of Alirocumab After Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score–Matched Analysis of the ODYSSEY OUTCOMES Trial
por: Schwartz, Gregory G., et al.
Publicado: (2021)

Long‐Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5 Years of Placebo‐Controlled Observation in the ODYSSEY OUTCOMES Trial
por: Goodman, Shaun G., et al.
Publicado: (2023)

Effect of alirocumab on cataracts in patients with acute coronary syndromes
por: Suc, Gaspard, et al.
Publicado: (2023)

Correction: Effect of alirocumab on cataracts in patients with acute coronary syndromes
por: Suc, Gaspard, et al.
Publicado: (2023)

Risk of adverse coronavirus disease 2019 outcomes for people living with HIV
por: Mellor, Maya M., et al.
Publicado: (2021)

Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
por: Schwartz, Gregory G., et al.
Publicado: (2021)

Patterns of Epistasis between Beneficial Mutations in an Antibiotic Resistance Gene
por: Schenk, Martijn F., et al.
Publicado: (2013)

Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial( )
por: Tardif, Jean Claude, et al.
Publicado: (2022)

Epistasis Constrains Mutational Pathways of Hemoglobin Adaptation in High-Altitude Pikas
por: Tufts, Danielle M., et al.
Publicado: (2015)

Phenoscape: Identifying Candidate Genes for Evolutionary Phenotypes
por: Edmunds, Richard C., et al.
Publicado: (2016)

Anisotropic Isolation by Distance: The Main Orientations of Human Genetic Differentiation
por: Jay, Flora, et al.
Publicado: (2013)

The Diversity and Molecular Evolution of B-Cell Receptors during Infection
por: Hoehn, Kenneth B., et al.
Publicado: (2016)

Transmission between Archaic and Modern Human Ancestors during the Evolution of the Oncogenic Human Papillomavirus 16
por: Pimenoff, Ville N., et al.
Publicado: (2017)

Experimental Evidence for Enhanced Receptor Binding by Rapidly Spreading SARS-CoV-2 Variants
por: Laffeber, Charlie, et al.
Publicado: (2021)

Cis-Regulatory Changes Associated with a Recent Mating System Shift and Floral Adaptation in Capsella
por: Steige, Kim A., et al.
Publicado: (2015)

Following the Footsteps of Chlamydial Gene Regulation
por: Domman, D., et al.
Publicado: (2015)

MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability
por: Katoh, Kazutaka, et al.
Publicado: (2013)

Strong Heterogeneity in Mutation Rate Causes Misleading Hallmarks of Natural Selection on Indel Mutations in the Human Genome
por: Kvikstad, Erika M., et al.
Publicado: (2014)

Mutational Biases Influence Parallel Adaptation
por: Stoltzfus, Arlin, et al.
Publicado: (2017)

Genetic Landscapes Reveal How Human Genetic Diversity Aligns with Geography
por: Peter, Benjamin M, et al.
Publicado: (2020)

BUSCO Applications from Quality Assessments to Gene Prediction and Phylogenomics
por: Waterhouse, Robert M, et al.
Publicado: (2018)

Co-Option and De Novo Gene Evolution Underlie Molluscan Shell Diversity
por: Aguilera, Felipe, et al.
Publicado: (2017)

How and Why Overcome the Impediments to Resolution: Lessons from rhinolophid and hipposiderid Bats
por: Foley, Nicole M., et al.
Publicado: (2015)

At the Transition from Invertebrates to Vertebrates, a Novel GnRH-Like Peptide Emerges in Amphioxus
por: Roch, Graeme J., et al.
Publicado: (2014)

SARS-CoV-2 live virus neutralization after four COVID-19 vaccine doses in people with HIV receiving suppressive antiretroviral therapy
por: Cheung, Peter K., et al.
Publicado: (2023)

Possible Loss of the Chloroplast Genome in the Parasitic Flowering Plant Rafflesia lagascae (Rafflesiaceae)
por: Molina, Jeanmaire, et al.
Publicado: (2014)

Inference of Epistatic Effects Leading to Entrenchment and Drug Resistance in HIV-1 Protease
por: Flynn, William F., et al.
Publicado: (2017)

Neuroprotective maraviroc monotherapy in simian immunodeficiency virus-infected macaques: reduced replicating and latent SIV in the brain
por: Kelly, Kathleen M., et al.
Publicado: (2013)

The First Venomous Crustacean Revealed by Transcriptomics and Functional Morphology: Remipede Venom Glands Express a Unique Toxin Cocktail Dominated by Enzymes and a Neurotoxin
por: von Reumont, Björn M., et al.
Publicado: (2014)

Phylogenomic Evidence Overturns Current Conceptions of Social Evolution in Wasps (Vespidae)
por: Piekarski, Patrick K, et al.
Publicado: (2018)

Structural Patching Fosters Divergence of Mitochondrial Ribosomes
por: Petrov, Anton S, et al.
Publicado: (2019)

Strong correlations between power-law growth of COVID-19 in four continents and the inefficiency of soft quarantine strategies
por: Manchein, Cesar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iik1v4qhohjajijg8g67perihv